⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23015518 | 0.81 | — | — | |
| SCHEMBL19870668 | 0.80 | ALOX15 (0.34) | — | |
| SCHEMBL12119536 | 0.78 | — | — | |
| SCHEMBL7081593 | 0.78 | — | — | |
| SCHEMBL348669 | 0.78 | — | — | |
| Acetic Acid SCHEMBL27364283 | 0.77 | FFAR3 (0.35) | — | |
| Guanidino Acetate SCHEMBL28619528 | 0.77 | EGLN1 (0.43) | — | |
| Guanidino Acetate SCHEMBL1097127 | 0.77 | CTH (0.40) | — | |
| Guanidino Acetate SCHEMBL27413696 | 0.76 | EGLN1 (0.41) | — | |
| Guanidino Acetate SCHEMBL33970 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023286057-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | FORTEPHEST LTD (IL) | 2023-01-19 | — | — | WO | disclosed |
| CN-111479875-B | Moisture-curable composition | 科思创德国股份有限公司 | 2022-11-15 | — | — | CN | disclosed |
| US-11352325-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2022-06-07 | — | — | US | disclosed |
| CN-113710746-A | Two-component composition having high strength | SIKA技术股份公司 | 2021-11-26 | — | — | CN | disclosed |
| EP-2897622-B1 | METHODS FOR TREATMENT OR PREVENTION OF DAMAGE RESULTING FROM RADIATION | SYNEDGEN INC (US) | 2021-04-21 | — | — | EP | disclosed |
| WO-2021034548-A1 | MITOCHONDRIAL MODULATION TO IMPROVE METABOLIC SYNDROME DURING AGING | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2021-02-25 | — | — | WO | disclosed |
| CN-111479875-A | Moisture-curable composition | 科思创德国股份有限公司 | 2020-07-31 | — | — | CN | disclosed |
| CN-111479628-A | Moisture-curable composition | 科思创德国股份有限公司 | 2020-07-31 | — | — | CN | disclosed |
| EP-2555760-B1 | CHITOSAN DERIVATIVES FOR THE TREATMENT OF MUCOSITIS OR ULCERATION | SYNEDGEN INC (US) | 2019-10-16 | — | — | EP | disclosed |
| US-20170304355-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | SYNEDGEN, INC. (US) | 2017-10-26 | — | — | US | disclosed |
| WO-2010056896-A1 | CHITOSAN DERIVATIVES TO TREAT ANIMALS OR OPTIMIZE ANIMAL HEALTH | SYNEDGEN, INC. (US) | 2010-05-20 | — | — | WO | disclosed |
| WO-2009061597-A1 | COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY | SCHERING CORPORATION (US) | 2009-05-14 | — | — | WO | disclosed |
| WO-2009061596-A1 | COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY | SCHERING CORPORATION (US) | 2009-05-14 | — | — | WO | disclosed |
| WO-2009061595-A1 | COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY | SCHERING CORPORATION (US) | 2009-05-14 | — | — | WO | disclosed |
| WO-2009052288-A1 | SPIRO-CONDENSED 1, 3, 4-THIADIAZOLE DERIVATIVES FOR INHIBITING KSP KINESIN ACTIVITY | SCHERING CORPORATION (US) | 2009-04-23 | — | — | WO | disclosed |
| US-20090036353-A1 | Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers | NOVO NORDISK A/S (DK) | 2009-02-05 | — | — | US | disclosed |
| US-20090036353-A1 | Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers | NOVO NORDISK A/S (DK) | 2009-02-05 | — | — | US | disclosed |
| US-20080194554-A1 | Hiv Protease Inhibitors | SMITHKLINE BEECHAM CORPORATION | 2008-08-14 | — | — | US | disclosed |
| US-20070281904-A1 | Chitosan-derivative compounds and methods of controlling microbial populations | UNITED STATES GOVERNMENT | 2007-12-06 | — | — | US | disclosed |
| WO-2006104646-A1 | HIV PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2006-10-05 | — | — | WO | disclosed |